Why the study?
Complex, high-risk PCI is increasingly performed in octogenarians, but limited data exist regarding CHiP types, trends, and outcomes in this age group.
How do the types, trends, and in-hospital outcomes of complex, high-risk percutaneous coronary intervention (CHiP) vary across different age groups?
How do the types, trends, and in-hospital outcomes of complex, high-risk percutaneous coronary intervention (CHiP) vary across different age groups?
Answers are grounded in this paper and cite their sources.
Complex, high-risk PCI in older patients, particularly octogenarians, is associated with significantly higher in-hospital mortality, major bleeding, and MACCE compared to younger patients.
BACKGROUND: Complex, high-risk percutaneous coronary intervention (PCI) (CHiP) is increasingly being undertaken in octogenarians. However, limited data exist on CHiP types, trends, and outcomes in the octogenarian. METHODS: This is a retrospective cohort study from a national registry dataset on CHiP undertaken in patients with stable angina in England and Wales (January 2006 and December 2017) according to three age groups (group 1 [G1]: < 65 years; group 2 [G2]: 65-79 years; and group 3 [G3]: ≥80 years). RESULTS: Of 424,290 elective PCI procedures, 138,831 (33.0%) were CHiP [G1: 46,832 (33.7%); G2: 59,544 (42.9%); G3: 32,455 (23.4%)]. Among CHiP types, chronic total occlusion (CTO) (49.2%), prior coronary artery bypass graft (CABG) (30.4%), and severe vascular calcification (21.8%) were common in G1; prior CABG (42.9%), CTO (32.9%), and severe vascular calcifications (27%) were common in G2; prior CABG (15.8%), severe vascular calcification (15.5%), and chronic renal failure (11.1%) were common CHiP among the octogenarians. The older age groups had higher adjusted odds (aOR) for adverse outcomes [G2: mortality, aOR 1.7, 95% confidence interval (CI): (1.3-2.3); major bleeding, aOR 1.3, 95% CI (1.1-1.5); MACCE, aOR 1.2, 95% CI (1.0-1.3); G3: mortality, aOR 2.6, 95%CI (1.9-3.6); major bleeding, aOR 1.4, 95% CI (1.1-1.7); MACCE, aOR 1.3, 95% CI (1.1-1.5)]. CONCLUSION: There were significant differences in the types of CHiP cases undertaken and clinical outcomes across age groups.
No takes yet. Share an insight, caveat, or question.
Shamkhani et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: